CV Sciences Inc (OTCMKTS:CVSI) announced plans to take part in this year’s Integrative Health Symposium, which will be held New York. The firm intends to showcase its market dominant hemp-based CBD oil product namely PlusCBD Oil. This is the second time that the firm is exhibiting at the Symposiums Annual conference which features drawn from a wide range of health care disciplines.
The evidence based conference offers health care practitioners an opportunity to learn, connect or collaborate with each other as they gain insights and techniques they could in corporate into their respective patience practices. It also creates an ideal environment for integrative practitioners and other interested parties to get educated and inspired about alternative health care approaches.
Following the announcement, CV Sciences has sent an invitation to conference attendees to visit its booth, labeled Booth 1011, where they can learn more about the CBD product line. At the exhibition, the firm will also showcase its line of products which are exclusively accessible to health care practitioners, besides giving our exclusive show specials and discounts to attendees.
During the conference, which is slated for February 22-24, CV Sciences team will make a presentation named,”Hemp-derived CBD,” at the Hilton Midtown in New York at 5.15 p.m on 23rd of February. Stuart Tomc, VP of Human Nutrition and Hector Lopez, MD, Scientific adviser to the company will make the presentation, which will demonstrate the interactions of CBD products with human endocannabionoid system. The presentation will also explain how the human endocannabinoid system relates to to pharmacokinetic and pharmacodynamic concepts of Cannabis Sativa L., an agricultural hemp cultivar.
Afterwards, the firm will participate round table panel featuring their practitioner distributor, Natural Partners. Under the theme,” CBD: State of the science, clinical applications and what we know,” the panel will take place on Saturday, 24th February 2018. It will feature a variety of panelists, including Dr. Hector Lopez, who will cover a wide range of topics related to the hemp CBD’s quality control, clinical applications and sourcing.